Clinical Trial Update: Onabotulinumtoxina Intradetrusorial Injections and NGF Expression

View source ↗

Summary

Completed clinical trial evaluating intradetrusorial injections of onabotulinumtoxinA and its impact on nerve growth factor (NGF) expression in bladder conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Hyperreflexia of Bladder
• Overactive Detrusor

Drugs mentioned

• OnabotulinumtoxinA (botulinum toxin type A)

Snippet

Sponsor: University Of Perugia | Conditions: Overactive Detrusor, Detrusor Hyperreflexia of Bladder | Status: COMPLETED